By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Catalyst Biosciences, Inc. 

260 Littlefield Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-871-0761 Fax: n/a



Company News
Catalyst Biosciences Reports First Quarter 2017 Financial Results and Provides Corporate Update 5/11/2017 9:10:14 AM
Catalyst Biosciences Announces Closing Of A $20.7 Million Underwritten Public Offering And Full Exercise Of Over-Allotment Option 4/13/2017 9:57:22 AM
Key Milestone Reached In Catalyst Biosciences’s Subcutaneous Factor IX Program 4/11/2017 9:44:57 AM
Catalyst Biosciences Announces Pricing of $18 Million Underwritten Public Offering 4/7/2017 8:49:20 AM
Why Catalyst Biosciences Nearly Tripled 3/29/2017 8:00:55 AM
Catalyst Biosciences Announces IND Approval In South Korea For Next-Generation Subcutaneous Factor IX Program 3/28/2017 11:51:16 AM
Catalyst Biosciences Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 3/8/2017 8:48:51 AM
Catalyst Biosciences Announces Promotion Of Andrew Hetherington To SVP Of Technical Operations 2/16/2017 8:04:17 AM
Catalyst Biosciences Highlights Hemophilia Clinical Development Plans At The 19th Annual BIO CEO & Investor Conference 2/14/2017 10:50:43 AM
Catalyst Biosciences To Present At 19th Annual BIO CEO & Investor Conference 2/3/2017 10:27:06 AM